| 1. |
Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med, 2003, 348(16): 1546-1554.
|
| 2. |
Warren HS. Strategies for the treatment of sepsis. N Engl J Med, 1997, 336(13): 952-953.
|
| 3. |
Otero RM, Nguyen HB, Huang DT, et al. Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest, 2006, 130(5): 1579-1595.
|
| 4. |
Adib-Conquy M, Cavaillon JM. Stress molecules in sepsis and systemic inflammatory response syndrome. FEBS Lett, 2007, 581(19): 3723-3733.
|
| 5. |
Jiyong J, Tiancha H, Wei C, et al. Diagnostic value of the soluble triggering receptor expressed on myeloid cells-1 in bacterial infection: a meta-analysis. Intensive Care Med, 2009, 35(4): 587-595.
|
| 6. |
Summah H, Tao LL, Zhu YG, et al. Pleural fluid soluble triggering receptor expressed on myeloid cells-1 as a marker of bacterial infection: a meta-analysis. BMC Infect Dis, 2011, 11: 280.
|
| 7. |
Soud DEM, Amin OAI, Amin AAI. New era "soluble triggering receptor expressed on myeloid cells-I" as a marker for early detection of infection in trauma patients. Egyptian Journal of Anaesthesia, 2011, 27(4): 267-272.
|
| 8. |
Barati M, Bashar FR, Shahrami R, et al. Soluble triggering receptor expressed on myeloid cells 1 and the diagnosis of sepsis. J Crit Care, 2010, 25(2): 362 e361-366.
|
| 9. |
Kofoed K, Andersen O, Kronborg G, et al. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care, 2007, 11(2): R38.
|
| 10. |
Latour-Péreza J, Alcalá-López A, García-García MA, et al. Diagnostic accuracy of sTREM-1 to identify infection in critically ill patients with systemic inflammatory response syndrome. Clin Biochem, 2010, 43(9): 720-724.
|
| 11. |
Gibot S, Kolopp-Sarda MN, Bene MC, et al. Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med, 2004, 141(1): 9-15.
|
| 12. |
Giamarellos-Bourboulis EJ, Mouktaroudi M, Tsaganos T, et al. Evidence for the participation of soluble triggering receptor expressed on myeloid cells-1 in the systemic inflammatory response syndrome after multiple trauma. J Trauma, 2008, 65(6): 1385-1390.
|
| 13. |
Gamez-Diaz LY, Enriquez LE, Matute JD, et al. Diagnostic Accuracy of HMGB-1, sTREM-1, and CD64 as Markers of Sepsis in Patients Recently Admitted to the Emergency Department. Acad Emerg Med, 2011, 18(8): 807-815.
|
| 14. |
Rivera-Chavez FA, Minei JP. Soluble triggering receptor expressed on myeloid cells-1 is an early marker of infection in the surgical intensive care unit. Surg Infect (Larchmt), 2009, 10(5): 435-439.
|
| 15. |
董裕康, 梁顯泉. 可溶性髓細胞觸發受體-1在膿毒癥診斷及病情判斷的價值. 中國急救醫學, 2012, 32(2): 115-119.
|
| 16. |
曾小莉, 張韶巖, 郭晶, 等. 可溶性髓樣細胞觸發受體1在膿毒癥中的表達和臨床意義. 中國呼吸與危重監護雜志, 2011, 10(6): 538-542.
|
| 17. |
黎麗芬. 髓樣細胞觸發受體1(TREM1)在危重病人膿毒癥的診斷價值. 2007.
|
| 18. |
Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest, 1992, 101(6): 1644-1655.
|
| 19. |
Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol, 2003, 3: 25.
|
| 20. |
Bowden J, Tierney JF, Copas AJ, et al. Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. BMC Med Res Methodol, 2011, 11: 41.
|
| 21. |
Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med, 1993, 12(14): 1293-1316.
|
| 22. |
Mitaka C. Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome. Clin Chim Acta, 2005, 351(1-2): 17-29.
|
| 23. |
Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother, 2011, 66(Suppl 2): 33-40.
|
| 24. |
Vouloumanou EK, Plessa E, Karageorgopoulos DE, et al. Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis. Intensive Care Med, 2011, 37(5): 747-762.
|
| 25. |
Uzzan B, Cohen R, Nicolas P, et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med, 2006, 34(7): 1996-2003.
|
| 26. |
Tang BM, Eslick GD, Craig JC, et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis, 2007, 7(3): 210-217.
|
| 27. |
Colonna M, Facchetti F. TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses. J Infect Dis, 2003, 187(Suppl 2): S397-401.
|
| 28. |
Tessarz AS, Cerwenka A. The TREM-1/DAP12 pathway. Immunol Lett, 2008, 116(2): 111-116.
|
| 29. |
Song F, Khan KS, Dinnes J, et al. Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy. Int J Epidemiol, 2002, 31(1): 88-95.
|
| 30. |
Cavaillon JM. Monocyte TREM-1 membrane expression in non-infectious inflammation. Criti care, 2009, 13(3): 152.
|
| 31. |
Ferat-Osorio E, Wong-Baeza I, Esquivel-Callejas N, et al. Triggering receptor expressed on myeloid cells-1 expression on monocytes is associated with inflammation but not with infection in acute pancreatitis. Criti care, 2009, 13(3): R69.
|
| 32. |
Bingold TM, Pullmann B, Sartorius S, et al. Soluble triggering receptor on myeloid cells-1 (sTREM-1) is expressed in the course of non-infectious inflammation after traumatic lung contusion: A prospective cohort study. Criti Care, 2011: R115.
|
